Finance

Lists
Why is TAKP34 down ७.४०%?
Dive Deeper
TAKP34:BVMF
Takeda Pharmaceutical Co Ltd BDR
R$ ९०.५४
-७.४०%
(-७.२३) 1D
अक्टोबर ६, १६:५६:०० GMT-३  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for TAKP34...
Open
R$ १०२.६५
High
R$ १०२.६५
Low
R$ ९०.००
Mkt. cap
५८.१७ अरब
Avg. vol.
३६.००
Volume
०.००
52-wk high
R$ १०२.६५
52-wk low
R$ ७०.८०
Shares outstanding
१.६० अरब
No. of employees
४७ हजार
Open
R$ १०२.६५
High
R$ १०२.६५
Low
R$ ९०.००
Mkt. cap
५८.१७ अरब
Avg. vol.
३६.००
Volume
०.००
52-wk high
R$ १०२.६५
52-wk low
R$ ७०.८०
Shares outstanding
१.६० अरब
No. of employees
४७ हजार
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
३ घण्टा पहिले
Should Phase 3 Psoriasis Win Require Action From Takeda Stock Investors?
AD HOC NEWS
AD HOC NEWS
·
५ घण्टा पहिले
Takeda stock after-hours: prior close at EUR 15.55
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd BDR
CEOChristophe Weber | Christophe Weber
Employees४७ हजार
Founded१७८१ जुन १२
Headquarters-
Sector-
Websitetakeda.com
Last report
२०२६ जुलाई ३०
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
१२.२० खरब / ११.५० खरब
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
११.१३ खरब
११.९२ खरब
१०.९५ खरब
१२.२० खरब
Cost of goods sold
३.८० खरब
४.०१ खरब
४.५३ खरब
४.०७ खरब
Cost of revenue
३.८० खरब
४.०१ खरब
४.५३ खरब
४.०७ खरब
Research and development expenses
१.६१ खरब
१.७५ खरब
१.८८ खरब
१.६७ खरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.५४ खरब
२.८३ खरब
२.९२ खरब
२.८७ खरब
Operating expense
५.६३ खरब
६.६१ खरब
५.२० खरब
६.१३ खरब
Total operating expenses
९.४३ खरब
१०.६२ खरब
९.७३ खरब
१०.१९ खरब
Operating income
१.७० खरब
१.२९ खरब
१.२२ खरब
२.०१ खरब
Other non operating income
७७.९६ अरब
-१.९७ खरब
१.८२ खरब
-२८.१४ अरब
EBT including unusual items
२८.१७ अरब
१.३४ खरब
-४.५५ खरब
१.६३ खरब
EBT excluding unusual items
१.२९ खरब
१.१४ खरब
७१.४९ अरब
१.६२ खरब
Income tax expense
३९.९० अरब
३०.१३ अरब
-८६.६२ अरब
४९.४६ अरब
Effective tax rate
१४१.६४%
२२.५१%
१९.०४%
३०.४०%
Other operating expenses
१६.१२ अरब
६७.१३ अरब
-६४.२७ अरब
५३.१७ अरब
Net income
-११.८० अरब
१.०४ खरब
-३.६८ खरब
१.१३ खरब
Net profit margin
-१.०६%
८.७०%
-३३.६६%
९.२८%
Earnings per share
-
-
-
-
Interest and investment income
४३.९२ अरब
१.८१ खरब
-
२४.६१ अरब
Interest expense
-१.६१ खरब
-
-२.४० खरब
-३५.७० अरब
Net interest expenses
-१.१७ खरब
१.८१ खरब
-२.४० खरब
-११.०९ अरब
Depreciation and amortization charges
-
-
-
-
EBITDA
३.५५ खरब
३.२० खरब
१.९३ खरब
३.६४ खरब
Gain or loss from assets sale
३०.३० करोड
३५.८० करोड
१.४६ अरब
-६.०० अरब
AI content may include mistakes. Learn more
Google एपहरू